Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
15 hedge funds and large institutions have $101K invested in Liminal BioSciences Inc. Common Shares in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 7 reducing their positions, and 3 closing their positions.
21% less funds holding
Funds holding: 19 → 15 (-4)
40% less capital invested
Capital invested by funds: $167K → $101K (-$66K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 7
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$13K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10K |
| 3 |
Renaissance Technologies
New York
|
-$8.93K |
| 4 |
Morgan Stanley
New York
|
-$6.87K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
National Bank of Canada
Montreal,
Quebec, Canada
| $41K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $20K | -$8.93K | -1,801 | -27% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $15.5K | -$94 | -19 | -0.5% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $9K | – | – | – |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $7K | -$853 | -172 | -9% |
|
6
Two Sigma Advisers
New York
| $5K | – | – | – |
|
|
ECM
7
Estabrook Capital Management
New York
| $2.1K | – | – | – |
|
|
IA
8
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
TWC
9
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $33 | – | – | – |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$13K | -2,617 | Closed |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10K | -1,976 | Closed |
|
|
12
Morgan Stanley
New York
| – | -$6.87K | -1,386 | -100% |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$3.79K | -764 | -100% |
|
14
Simplex Trading
Chicago,
Illinois
| – | -$298 | -60 | -90% |
|
15
Group One Trading
Chicago,
Illinois
| – | -$30 | -6 | -15% |
|
LMNL Hedge Fund Activity: Q3 2022 in Review
15 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q3 2022, worth a combined $101K — down 40% from $167K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of LMNL and 0 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, exiting entirely with an estimated $13K sold.
- 15 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q3 2022, down from 19 in Q2 2022.
- Funds reported $101K of Liminal BioSciences Inc. Common Shares stock for Q3 2022, down 40% quarter-over-quarter.
- 0 funds opened new Liminal BioSciences Inc. Common Shares positions in Q3 2022 and 3 closed out, a net change of -3 holders.
- The largest Liminal BioSciences Inc. Common Shares seller in Q3 2022 was Citadel Advisors, an estimated $13K sold.
Based on aggregated 13F filings for Q3 2022.